SCHOTT Pharma AG & Co KgaA

Common Name

SCHOTT Pharma AG & Co

Country

Germany

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

4,775

Ticker

1SXP

Exchange

XETRA

Website

www.schott-pharma.com

Description

Schott Pharma AG & Co. KGaA is a prominent entity in the pharmaceutical packaging industry, known for its innovative approach to developing glass and polymer syringes, cartridges, and vials. These pro... Show more

Income Statement Balance Sheet Group Entities

SCHOTT Pharma AG & Co's Financial Statements Preview

Below are the financial statements of SCHOTT Pharma AG & Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in thousands of EUR	2024 as of 2024-09-30	2023 as of 2023-09-30
Intangible assets	30,467^a	30,941^a
Property, plant and equipment	723,490^a	637,805^a
Investments accounted for using the equity method	85,056^a	79,055^a
Deferred tax liabilities	14,330^a	14,828^a
Other financial assets	6^a	18^a
Other non-financial assets	319^a	843^a
Non-current assets	853,668^a	763,490^a
Inventories	140,445^a	138,943^a
Contract assets	60,733^a	58,208^a
Trade receivables	168,487^a	156,652^a
Trade receivables - SCHOTT Group	6,401^a	8,838^a
Financial receivables - SCHOTT Group	141,339^a	35,485^a
Income tax assets	8,226^a	3,953^a
Other financial assets	7,732^a	8,521^a
Other non-financial assets	32,056^a	33,381^a
Cash and cash equivalents	23,182^a	24,357^a
Current assets	588,601^a	468,338^a
Total assets	1,442,269^a	1,231,828^a
Subscribed capital	150,615^a	150,615^a
Capital reserves	494,481^a	494,481^a
Generated Group equity	158,483^a	36,953^a
Accumulated other Group equity	-13,173^a	8,382^a
Equity attributable to limited liability shareholders of SCHOTT Pharma AG & Co. KGaA	790,406^a	690,431^a
Non-controlling interests	1,863^a	1,748^a
Equity	792,269^a	692,179^a
Provisions for pensions and similar commitments	27,204^a	18,777^a
Provisions for income taxes	1,110^a	3,557^a
Other provisions	5,994^a	6,001^a
Deferred tax liabilities	20,515^a	24,822^a
Contract liabilities	78,611^a	66,139^a
Other financial liabilities	81,086^a	69,207^a
Non-current liabilities	214,520^a	188,503^a
Other provisions	10,262^a	5,263^a
Accrued liabilities	49,825^a	59,003^a
Contract liabilities	22,938^a	17,776^a
Trade payables	68,933^a	60,529^a
Trade payables - SCHOTT Group	26,579^a	30,115^a
Financial payables - SCHOTT Group	200,537^a	137,474^a
Income tax liabilities	35,328^a	20,397^a
Other financial liabilities	9,945^a	9,100^a
Other non-financial liabilities	11,133^a	11,489^a
Current liabilities	435,480^a	351,146^a
Total equity and liabilities	1,442,269^a	1,231,828^a

Download Data

Verified Sources Behind SCHOTT Pharma AG & Co’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SCHOTT Pharma AG & Co’s data sources below and access millions more through our Disclosure Search.

a. SCHOTT Pharma AG & Co's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

SCHOTT Pharma AG & Co KgaA

SCHOTT Pharma AG & Co's Financial Statements Preview

Verified Sources Behind SCHOTT Pharma AG & Co’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Sartorius AG

Carl Zeiss Meditec AG

Gerresheimer AG

Fielmann Group AG

Biontech SE

Fresenius SE & Co KGaA